Figure 6A showed results of the top 15 GO analyses (adjusted p < 0.01), suggesting that many biological processes may be involved in ALI/ARDS treatment, including cytokine-mediated signaling pathway, positive regulation of phosphatidylinositol 3-kinase signaling, and positive regulation of protein kinase B signaling. The gene discussed is AKT1; the disease is acute respiratory distress syndrome.